RespireRx Pharmaceuticals Inc. Announces the Publication of a Case Report in which KRM-II-81 Totally Suppressed Epileptiform Activity in Brain Tissue Surgically Removed from Epileptic Patient
Stock Information for RespireRx Pharmaceuticals Inc
Loading
Please wait while we load your information from QuoteMedia.